The possible reasons for an increase in the concentration of middle-weight molecules in pathology
Chalenko, V.V.
Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 4: 13-14
1991
ISSN/ISBN: 0031-2991 PMID: 1798639 Document Number: 376227
Human plasma and blood were treated by kaolin, thromboplastin, streptokinase, phytohemagglutinin, hydrogen peroxide, and Fe2+. An increase in the amount of median-mass substances was found after incubation. The obtained data showed that activation of limited proteolysis, immunity, and peroxidation could be the cause of increase of median-mass substances in pathological conditions.
Document emailed within 1 workday
Related Documents
Madry, K.; Lutz, W.; Grande, G. 1978: Effect of trasylol on the concentration of middle-sized molecules of urea and creatinine in the plasma in acute experimental uremia Polski Tygodnik Lekarski 33(1): 5-8Gudim, V.I.; Sigalla, P.; Ivanova, V.S.; Oldag, K. 1980: Concentration of middle-sized molecules in the blood of children with chronic renal failure during treatment with short-term hemodialysis Voprosy Meditsinskoi Khimii 26(6): 742-746
Bobrovnik, S.A. 2000: Determination of the concentration of ligand-specific molecules, found in mixtures with ligand-nonspecific molecules Ukrains'kyi Biokhimichnyi Zhurnal 72(1): 113-119
Barghini, G. 1983: The dynamics of physical development (height and weight) in relation to sex maturation in girls observed continuously between the ages of 6 and 17 in longitudinal studies. II. Height and weight growth rate curves (annual height and weight increase) Minerva Pediatrica 35(17): 811-815
Fescina, R.H. 1983: Weight increase during pregnancy. Method for its calculation when the normal weight is unknown Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau 95(2): 156-162
Doszpod, J.; Gaál, A.; Gáti, I. 1974: Concentration and in vitro release of placental human chorionic somatomammotropin (HCS) in the case of foetuses of normal weight and with intrauterine weight retardation Acta Physiologica Academiae Scientiarum Hungaricae 45(1-2): 63-68
Von Hartitzsch, B.; Hoenich, N.A.; Reed, B.R.; Kerr, D.N. 1972: The clearance of middle size molecules Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 9: 658-660
Matulewicz-Gilewicz, J.; Popławski, A. 1997: Uremic middle molecules in chronic renal insufficiency Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 2(9): 199-200
Cambi, V.; Buzio, C.; Arisi, L.; Calderini, C.; David, S.; Manari, A.; Bono, F.; Zanelli, P. 1981: Vascular stability and middle molecules removal in hypertonic haemodiafiltration Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 18: 681-689
Eriukhin, I.A.; Belyĭ, V.I.; Khanevich, M.D.; Tupikova, Z.A.; Vagner, V.K. 1987: Role of middle mass molecules in the pathogenesis of endotoxicosis in peritonitis Vestnik Khirurgii Imeni I. I. Grekova 138(1): 5-9
Domzal, K.; Domzal, J. 1975: Determination of concentration of digitalis glycosides in the body performed for therapeutic reasons Postepy Higieny i Medycyny Doswiadczalnej 29(4): 483-499
Severini, G.; Malaguti-Aliberti, L. 1985: Effects of uremic middle molecules on the activity of erythrocyte lactate dehydrogenase (LDH) Annali Dell'istituto Superiore di Sanita 21(3): 357-361
Araújo, A.José.de. 2019: Reasons for smoking or reasons for quitting, that is the question: can administering the Modified Reasons for Smoking Scale make a difference in clinical practice? Jornal Brasileiro de Pneumologia: Publicacao Oficial da Sociedade Brasileira de Pneumologia e Tisilogia 45(4): E20190253
Lur'e, B.L.; Lobakov, A.I.; Kaliman, I.M. 1986: Effect of plasmapheresis on the content of peptide middle molecules in severe pyo-septic complications Laboratornoe Delo 2: 95-98
Rico Irlés, J.; Díaz Penalva, M.D.; Girón Irueste, F.; del Arbol Navarro, J.L.; Raya Muñoz, J. 1995: A retrospective study of alcoholism at the Hospital Universitario de Granada. II. The reasons for admission and associated pathology in these patients Anales de Medicina Interna 12(2): 55-60
Saito, A.; Suzuki, I.; Chung, T.G.; Okamoto, T.; Hotta, T. 1986: Separation of an inhibitor of erythropoiesis in "middle molecules" from hemodialysate from patients with chronic renal failure Clinical Chemistry 32(10): 1938-1941
Tupikova, Z.A. 1983: Effect of middle mass molecules from blood sera of patients with burns on the process of lipid peroxidation Voprosy Meditsinskoi Khimii 29(3): 108-111
Volchegorskiĭ, I.A.; Diatlov, D.A.; Kulikov, L.M.; L'vovskaia, E.I.; Mel'lnikov, I.I.; Sashenkov, S.L.; Efimenko, G.P. 1996: "Middle molecules" and products of lipid peroxidation as a system of non-specific regulators of hemodynamics in competitive skiiers Fiziologiia Cheloveka 22(6): 106-110
Turianitsa, I.M.; Pashchenko, A.E.; Fedorovich, T.M.; Nemesh, I.I.; Mishanich, I.I. 1988: Changes in the blood serum levels of middle molecules in patients with duodenal ulcer after sanatorium-health resort treatment Vrachebnoe Delo 1988(6): 61-63
Kaplan, B.; Gotfried, M.; Ravid, M. 1986: Amino acid containing compounds in uremic serum-search for middle molecules by high performance liquid chromatography Clinical Nephrology 26(2): 66-71